Company page

Biomea Fusion, Inc.

Biomea Fusion, Inc. is a public company traded under the ticker BMEA in the American market, with a market capitalization of approximately $85.3 million. The company focuses on developing innovative therapies for cancer treatment. Biomea Fusion is committed to advancing its research and development efforts to address unmet medical needs in oncology.